induction of remission การใช้

Budesonide assists in the induction of remission in people with active ulcerative colitis.
They have a duration of action of months, making it unwieldy to use them for induction of remission.
In January 2008, the FDA approved natalizumab for both induction of remission and maintenance of remission for moderate to severe Crohn's disease.
The most commonly prescribed oral steroid is prednisone, which is typically dosed at 0.5 mg / kg for induction of remission in Crohn's disease.
In January 2008, the FDA approved natalizumab for both induction of remission and maintenance of remission for moderate to severe Crohn's disease, though it has not been approved for this use in the European Union due to concerns over its risk / benefit ratio.